Nabumetone and Ranexa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nabumetone (nabumetone) and Ranexa (ranolazine). Common drug interactions include chronic kidney disease among females and hallucination among males.

The phase IV clinical study analyzes what interactions people have when they take Nabumetone and Ranexa. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Nabumetone?

Nabumetone has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 9,554 Nabumetone users. Check the latest studies of Nabumetone.

What is Ranexa?

Ranexa has active ingredients of ranolazine. It is often used in angina. eHealthMe is studying from 11,758 Ranexa users. Check the latest studies of Ranexa.

On Jul, 20, 2026

18 people who take Nabumetone and Ranexa together, and have interactions are studied.

Nabumetone and Ranexa drug interactions.

What are the common drug interactions of Nabumetone and Ranexa, by gender? *:

female:

Chronic kidney disease
Age-related macular degeneration
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Psoriasis (immune-mediated disease that affects the skin)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Asthenia (weakness)
Balance disorder
Blood calcium increased
Blood parathyroid hormone increased

male:

Hallucination (an experience involving the perception of something not present)
Abdominal discomfort
Neuropathy peripheral (surface nerve damage)
Platelet count decreased
Tibia fracture (fracture of lower leg bone)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Burning sensation
Chronic kidney disease
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Nabumetone and Ranexa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal injury (kidney injury)

50-59:

Age-related macular degeneration
Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
Psoriasis (immune-mediated disease that affects the skin)

60+:

Chronic kidney disease
Hallucination (an experience involving the perception of something not present)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Abdominal discomfort
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Platelet count decreased
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 22.22%
Indigestion: 3 people, 16.67%
Stress And Anxiety: 3 people, 16.67%
High Blood Pressure: 3 people, 16.67%
Infection: 2 people, 11.11%
Urinary Tract Infection: 2 people, 11.11%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 11.11%
Hypersensitivity: 2 people, 11.11%
High Blood Cholesterol: 2 people, 11.11%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Nabumetone and Ranexa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously